In line, selective inhibition of IL-10 was associated with increased lipogenesis, overexpression of inflammatory mediators, and IR in the liver of mice with HFD-induced NAFLD [90]. Here, IL10 is linked to metabolic dysfunction-associated steatotic liver disease.